Private Equity

Healthcare

Mental health, neurodiversity M&A grows further; Bridgepoint to acquire Kayne Anderson Real Estate

Investcorp has established a new software engineering platform with NetRom Software and Trivium eSolutions as the founding businesses.

4 min read · 29 June 2026

Radiology deals attract Archimed, Grovecourt, Kain Capital; Latticework and Edgehill back acquisition of CDMO brands

Highlight private equity-backed radiology deals in a listicle; exploring newly announced CDMO add-on deals involving Latticework Capital and Edgehill-backed Life Science Connect.

3 min read · 26 June 2026

PE targets radiology assets: 5 deals

Archimed, HCAP, Hg and Kain Capital are among the PE firms pursuing transactions in the radiology sector.

4 min read · 26 June 2026

Advent to acquire Japanese home care operator JWB

The seller is MBK Partners.

1 min read · 25 June 2026

Chicago Pacific Founders backs health tech firm Attune

The investment accelerates Attune's platform roadmap, expanding omnichannel capabilities, deepening integrations, and extending clinical use cases across the full range of health plans, provider groups, and care organizations.

1 min read · 24 June 2026

Thoma Bravo backs occupational health software firm padoa

Padoa serves occupational health centers, employers and employees across France and Europe.

2 min read · 24 June 2026

Teleo Capital scoops up pharma manufacturing intelligence platform Modersys

The seller was Applied Materials, Inc.

1 min read · 23 June 2026

PE-backed Life Science Connect picks up biopharma brands PharmaSource and CDMO Live

The acquisition will form a biopharma outsourcing platform, bringing together PharmaSource, CDMO Live Europe, CDMO Live Americas and External Manufacturing Leaders.

2 min read · 23 June 2026

Incline Equity invests in medical and health physics testing provider West Physics

West Physics provides testing services for medical imaging equipment such as MRI, CT and X-ray.

1 min read · 23 June 2026

AI impacting all of healthcare – but not at same pace, says Mérieux’s Jean-François Billet; Private capital ‘keen’ to be part of UK defense plans

'Drug discovery is accelerated by AI because you can screen a lot of compounds much faster,' Jean-François Billet, head of buyout at Mérieux, told PE Hub.

3 min read · 23 June 2026

Showing 251 to 260 of 5,652 results
1…2527…566